Carregant...

Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Introduction The T790M resistance mutation is present in about one-half of epidermal growth factor receptor (EGFR)-positive advanced non-small cell lung cancer (NSCLC) patients at disease progression. We aimed to assess the prevalence of this mutation in a real-world setting and the clinical impact...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cureus
Autors principals: Pereira, Isabel, Gaspar, Cátia, Pina, Marta, Azevedo, Isabel, Rodrigues, Ana
Format: Artigo
Idioma:Inglês
Publicat: Cureus 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7810175/
https://ncbi.nlm.nih.gov/pubmed/33489541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.12128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!